BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BXPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

BXPHARMA 28-Jan-2021

(Q2 Un-audited): Consolidated EPS was Tk. 2.54 for October-December 2020 as against Tk. 1.89 for October-December 2019; Consolidated EPS was Tk. 4.95 for July-December 2020 as against Tk. 3.83 for July-December 2019. Consolidated NOCFPS was Tk. 4.91 for July-December 2020 as against Tk. 9.14 for July-December 2019. Consolidated NAV per share was Tk. 76.45 as on December 31, 2020 and Tk. 75.66 as on December 31, 2019.

BXPHARMA 15-Nov-2020

(Q1 Un-audited): Consolidated EPS was Tk. 2.65 for July-September 2020 as against Tk. 2.13 for July-September 2019; Consolidated NOCFPS was Tk. 3.00 for July-September 2020 as against Tk. 4.59 for July-September 2019. NAV per share was Tk. 82.78 as on September 30, 2020 and Tk. 75.09 as on September 30, 2019.

BXPHARMA 29-Oct-2020

The Board of Directors has recommended 15% cash and 10% stock dividend for the year ended on June 30, 2020. Date of AGM: 19.12.2020, Time: 10:30 AM, Venue: Digital Platform. Record Date: 25.11.2020. The Company has also reported Consolidated EPS of Tk. 8.67, Consolidated NAV per share of Tk. 80.12 and Consolidated NOCFPS of Tk. 13.67 for the year ended on June 30, 2020 as against Tk. 7.48, Tk. 72.96 and Tk. 7.30 respectively for the same period of the previous year.

BXPHARMA 23-Jun-2020

(Q3 Un-audited): Consolidated EPS was Tk. 2.22 for January-March 2020 as against Tk. 1.84 for January-March 2019; Consolidated EPS was Tk. 6.48 for July 2019-March 2020 as against Tk. 5.51 for July 2018-March 2019. Consolidated NOCFPS was Tk. 9.83 for July 2019-March 2020 as against Tk. 6.48 for July 2018-March 2019. Consolidated NAV per share was Tk. 77.88 as on March 31, 2020 and Tk. 70.99 as on March 31, 2019.

BXPHARMA 29-Jan-2020

(Q2 Un-audited): Consolidated EPS was Tk. 2.12 for October-December 2019 as against Tk. 1.81 for October-December 2018; Consolidated EPS was Tk. 4.26 for July-December 2019 as against Tk. 3.67 for July-December 2018. Consolidated NOCFPS was Tk. 9.14 for July-December 2019 as against Tk. 2.10 for July-December 2018. Consolidated NAV per share was Tk. 75.66 as on December 31, 2019 and Tk. 69.15 as on December 31, 2018.

BXPHARMA 14-Nov-2019

(Q1 Un-audited): Consolidated EPS was Tk. 2.13 for July-September 2019 as against Tk. 1.86 for July-September 2018; Consolidated NOCFPS was Tk. 4.59 for July-September 2019 as against Tk. 1.05 for July-September 2018. NAV per share was Tk. 75.09 as on September 30, 2019 and Tk. 68.59 as on September 30, 2018.

BXPHARMA 29-Oct-2019

(Continuation news of BXPHARMA): The Company has also reported Consolidated EPS of Tk. 7.48, Consolidated NAV per share of Tk. 72.96 and Consolidated NOCFPS of Tk. 7.30 for the year ended on June 30, 2019 as against Tk. 6.25, Tk. 66.78 and Tk. 4.49 respectively for the same period of the previous year. (end)

BXPHARMA 29-Apr-2019

(Q3 Un-audited): Consolidated EPS was Tk. 1.84 for January-March 2019 as against Tk. 1.49 for January-March 2018; Consolidated EPS was Tk. 5.51 for July 2018-March 2019 as against Tk. 4.74 for July 2017-March 2018. Consolidated NOCFPS was Tk. 6.48 for July 2018-March 2019 as against Tk. 3.83 for July 2017-March 2018. Consolidated NAV per share was Tk. 70.99 as on March 31, 2019 and Tk. 65.26 as on March 31, 2018.

BXPHARMA 30-Jan-2019

(Q2 Un-audited): Consolidated EPS was Tk. 1.81 for October-December, 2018 as against Tk. 1.66 for October-December, 2017; Consolidated EPS was Tk. 3.67 for July-December, 2018 as against Tk. 3.25 for July-December, 2017. Consolidated NOCFPS was Tk. 2.10 for July-December, 2018 as against Tk. 3.14 for July-December, 2017. Consolidated NAV per share was Tk. 69.15 as on December 31, 2018 and Tk. 63.77 as on December 31, 2017.

BXPHARMA 14-Nov-2018

(Q1 Un-audited): Consolidated EPS was Tk. 1.86 for July-September, 2018 as against Tk. 1.59 for July-September, 2017; Consolidated NOCFPS was Tk. 1.05 for July-September, 2018 as against Tk. 1.56 for July-September, 2017. Consolidated NAV per share was Tk. 68.59 as on September 30, 2018 and Tk. 63.36 as on September 30, 2017. As the company acquired Nuvista Pharma on 2.4.18, the comparative prior period figures are reported in the consolidated figures.

Previous Next page